Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179137 | SCV000231337 | pathogenic | not provided | 2015-02-17 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003398899 | SCV004110144 | likely pathogenic | COL5A1-related disorder | 2024-08-27 | no assertion criteria provided | clinical testing | The COL5A1 c.4184delC variant is predicted to result in a frameshift and premature protein termination (p.Pro1395Glnfs*93). To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. Frameshift variants in COL5A1 are expected to be pathogenic. This variant is interpreted as likely pathogenic. |